Author

R. Meyers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

H. J. Kim· 2 shared J. Duffner· 2 shared J. Hixon· 2 shared J. P. Taylor· 2 shared J. Wu· 2 shared K. Wong· 2 shared R. Lemieux· 2 shared A. Astrinidis· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

H. J. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication

Z. Yang, B. A. Johnson, V. A. Meliopoulos, X. Ju, P. Zhang, M. P. Hughes, J. Wu, K. P. Koreski, T.-C. Chang, G. Wu, J. Hixon, J. Duffner, K. Wong, R. Lemieux, K. G. Lokugamage, , J. P. Taylor

This study identifies the role of G3BP1-N interaction in SARS-CoV-2 replication by showing that disrupting this interaction reduces viral replication and pathogenesis.

bioRxiv · Jun 29, 2023 · PreprintCell Biology

Identification of small molecule inhibitors of G3BP-driven stress granule formation

B. D. Freibaum, J. Messing, H. Nakamura, U. Yurtsever, J. Wu, H. J. Kim, J. Hixon, R. Lemieux, J. Duffner, W. Huynh, K. Wong, M. White, C. Lee, R. Meyers, R. D. Parker, J. P. Taylor

This study identifies two small molecules that inhibit G3BP-driven stress granule formation and dissolve pre-existing granules, showing broad efficacy across cell types and stressors.

bioRxiv · Jun 27, 2023Cell Biology

Combination of Volasertib and Rapamycin Inhibits the Regrowth of TSC2-Deficient Tumors

M. Valianou, E. Y. Zhang, D. L. Johnson, R. Meyers, M. M. Markiewski, M. Karbowniczek, L. M. Pfeffer, J. J. Yu, J. J. Bissler, A. Astrinidis

This study shows that combining volasertib and rapamycin inhibits tumor regrowth in TSC2-deficient models more effectively than rapamycin alone.

bioRxiv · Nov 2, 2022 · PreprintCancer Biology